SIA "UNIFARMA"
Copy
Copy
CopyRegistry data
Legal status
Company ID
CopyVAT code
CopyIncorporation date
Paid share capital
Registered share capital
Contacts
Company registration address
Copy
Website
-Latest events
from (18/11/2021)
2025-01-20
Change in beneficial owners2025-01-20
Change in officers2025-01-20
Unidentified type of change2023-08-04
Unidentified type of changeSuspensions
No suspension
Register and unlock the potential of dataReliability
Register and check the change of employees’ number over the years
Number of employees
19Debts
0.00 €
0 €* during past year
Register and check if company had lawsuits over the years
Lawsuits as defendant
1
Credit limit
***** €
Turnover
5-10 M €
+28.80 %Business linkages
5Linkages with other companies
Financial ratios
Net Profit (€)
1,560,087
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Register and
explore Okredo dataEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Register and
explore Okredo dataNet Profit (€)
1,560,087EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| 2022 |
|---|
| 4,436,583 |
| 260,975 |
| 1,791,207 |
| 1,746,817 |
| 102,754 |
| 49.82 |
| 39.37 |
| 5,586,455 |
| 2,575,206 |
| 1,914,349 |
| 6,247,312 |
| 2023 |
|---|
| 4,750,019 |
| 296,876 |
| 2,076,542 |
| 2,031,543 |
| 126,971 |
| 54.39 |
| 42.77 |
| 7,443,231 |
| 2,105,751 |
| 1,933,453 |
| 7,615,529 |
| 2024 |
|---|
| 6,118,126 |
| 322,007 |
| 1,618,002 |
| 1,560,087 |
| 82,110 |
| 43.32 |
| 25.50 |
| 8,777,948 |
| 2,088,383 |
| 2,386,391 |
| 8,479,940 |
Register and
explore Okredo data| 2024 |
|---|
| 6,118,126 |
| 322,007 |
| 1,618,002 |
| 1,560,087 |
| 82,110 |
| 43.32 |
| 25.50 |
| 8,777,948 |
| 2,088,383 |
| 2,386,391 |
| 8,479,940 |
Register and
explore Okredo dataTurnover (€)
2024
Turnover (€)
6,118,126 €
29 % *
Sales per employee (€)
322,007 €8 % *
Profit before tax (€)
1,618,002 €
-22 % *
Net Profit (€)
1,560,087 €-23 % *
Profit per employee (€)
82,110 €-35 % *
Total profitability (%)
43.32 %-20.35 % *
Net profitability (%)
25.50 %-40.38 % *
Equity (€)
8,777,948 €18 % *
Amounts Payable And Liabilities (€)
2,088,383 €
-1 % *
Non-current Assets (€)
2,386,391 €
23 % *
Current Assets (€)
8,479,940 €11 % *
Credit history
No. of unpaid debts
0
Largest debt
VID
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
VID
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Premium users: 1.00 credit
Creditor/Data source  | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Legal proceedings
Defendant
(2)
Plaintiff
(2)
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
03/02/2026C771506125C-15061-25 | Claimant:Biogen MA Inc. Respondent:MSN Labs Europe Limited | Reason: par nelikumīgu patenta izmantošanu Decision: Open | Rīgas pilsētas tiesa | 5 |  |
03/02/2026C771506125C-05627-26 | Claimant:Biogen MA Inc. Respondent:MSN Labs Europe Limited | Reason: par nelikumīgu patenta izmantošanu Decision: Open | Rīgas pilsētas tiesa | 1 | |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
10/03/2026C771019224C-00932-26 | Claimant:SIA "UNIFARMA" Respondent:Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" | Reason: naudas atmaksa un līguma izpilde Decision: Open | Rīgas pilsētas tiesa | 1 |  |
10/09/2025C771019224C-02443-25 | Claimant:SIA "UNIFARMA" Respondent:Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" | Reason: naudas atmaksa un līguma izpilde Decision: Open | Rīgas pilsētas tiesa | 3 | |
Public data
Data source | Information | Additional data |
|---|---|---|
 | Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2022 | Total amount: 694,980 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2021 | Total amount: 666,620 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2020 | Total amount: 505,100 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2019 | Total amount: 369,830 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2018
| Total amount: 345,670 |
Similar companies
Category:
Wholesale of pharmaceutical goodsComp. code:
40203177406Reg. date:
25/10/2018Turnover:
-No. of employees:
18Category:
Wholesale of pharmaceutical goodsComp. code:
40103731414Reg. date:
14/11/2013Turnover:
-No. of employees:
17Category:
Wholesale of pharmaceutical goodsComp. code:
40103677353Reg. date:
31/05/2013Turnover:
-No. of employees:
17Category:
Wholesale of pharmaceutical goodsComp. code:
40103629372Reg. date:
25/01/2013Turnover:
-No. of employees:
17Category:
Wholesale of pharmaceutical goodsComp. code:
40103314340Reg. date:
17/08/2010Turnover:
-No. of employees:
18